Sol-Gel Technologies (SLGL) EBIT Margin (2018 - 2026)
Sol-Gel Technologies (SLGL) posted EBIT Margin of -704.23% for Q2 2026, down 769.29 percentage points from 65.06% a year earlier and down 4273.67 percentage points from the prior quarter.
Powered by 
Analysis
Sol-Gel Technologies (SLGL) EBIT Margin (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Sol-Gel Technologies was -557.44%, down 613.31 percentage points year-over-year; for FY2025, it was -38.88%, up 65.25 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of +305.81 percentage points (FY2020 to FY2025).
- In prior years, Sol-Gel Technologies' EBIT Margin was -104.13% in FY2024 (+1781.65 pp), -1885.78% in FY2023 (-1467.44 pp), -418.34% in FY2022 (-430.80 pp) and 12.47% in FY2021 (+357.16 pp).
- Quarterly EBIT Margin has run from a low of -6205.00% in Q4 2022 to a high of 198333.33% in Q1 2022 over five years.
- On a year-over-year basis, EBIT Margin increased in four of the last eight quarters, with an average year-over-year change of +437.94 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q1 2022, with a gain of 197730.77 percentage points; the weakest was Q1 2023, with a drop of 194645.67 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was 3569.44% (Q1 2026), -490.09% (Q4 2025) and -1572.00% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Sol-Gel Technologies | 193.50 Mn | 47.91 Mn | - | -704.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -704.23% |
| Mar 31, 2026 | 3,569.44% |
| Dec 31, 2025 | -490.09% |
| Sep 30, 2025 | -1,572.00% |
| Jun 30, 2025 | 65.06% |
| Mar 31, 2025 | 879.63% |
| Dec 31, 2024 | -2,193.88% |
| Sep 30, 2024 | -15.44% |
| Jun 30, 2024 | 29.89% |
| Mar 31, 2024 | 1,440.34% |
| Dec 31, 2023 | -1,209.62% |
| Sep 30, 2023 | -2,961.03% |
| Jun 30, 2023 | -1,098.82% |
| Mar 31, 2023 | 3,687.67% |
| Dec 31, 2022 | -6,205.00% |
| Sep 30, 2022 | -1,388.89% |
| Jun 30, 2022 | 13.16% |
| Mar 31, 2022 | 198,333.33% |
| Dec 31, 2021 | 67.08% |
| Sep 30, 2021 | 95.21% |
API Access
Sol-Gel Technologies EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SLGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SLGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SLGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();